Efficacy and Safety of Secukinumab in Patients with Spondyloarthritis and Enthesitis at the Achilles Tendon: 52-weeks Results from a Randomized, Placebo-controlled Phase 3b Trial

被引：0
|
作者：
Behrens, Frank [1 ,2 ]
Sewerin, Philipp [3 ,4 ]
De Miguel, Eugenio [5 ]
Patel, Yusuf [6 ]
Batalov, Anastas [7 ]
Dokoupilova, Eva [8 ,9 ]
Kleinmond, Christine [10 ]
Pournara, Effie [11 ]
Shekhawat, Ankita [12 ]
Jentzsch, Claudia [13 ]
Wiedon, Annette [14 ]
Baraliakos, Xenofon [15 ]
机构：
[1] Goethe Univ, CIRI Rheumatol, Frankfurt, Germany
[2] Goethe Univ, Fraunhofer TMP, Frankfurt, Germany
[3] Univ Hosp Dusseldorf, Dept Rheumatol, Dusseldorf, Germany
[4] Univ Hosp Dusseldorf, Hiller Res Unit, Dusseldorf, Germany
[5] Hosp Univ La Paz, Dept Rheumatol, Madrid, Spain
[6] Hull Univ Teaching Hosp, Kingston Upon Hull, East Yorkshire, England
[7] Med Univ Plovdiv, Univ Hosp Kaspela, Plovdiv, Bulgaria
[8] Med Plus Sro, Uherske Hradiste, Czech Republic
[9] Univ Vet & Pharmaceut Sci, Fac Pharm, Dept Pharmaceut, Uherske Hradiste, Czech Republic
[10] ClinProject GmbH, Eurasburg, Germany
[11] Novartis Pharma AG, Basel, Switzerland
[12] Novartis Healthcare Private Ltd, Hyderabad, Telangana, India
[13] Novartis Pharma GmbH, Nurnberg, Germany
[14] Novartis Pharma GmbH, Nurnberg, Germany
[15] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0882
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
    Antoinette MaassenVanDenBrink
    Gisela M. Terwindt
    Joshua M. Cohen
    Steve Barash
    Verena Ramirez Campos
    Maja Galic
    Xiaoping Ning
    Mikko Kärppä
    The Journal of Headache and Pain, 2021, 22
  • [42] Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomized, placebo-controlled, phase 3 trial'
    Zhao, Yan
    Huang, Jin-Xian
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (07)
  • [43] Ianalumab (VAY736) Safety and Efficacy in Patients with Sjogren's Syndrome: 52 Week Results from a Randomized, Placebo-controlled, Phase 2b Dose-ranging Trial
    Doerner, Thomas
    Bowman, Simon J.
    Fox, Robert
    Mariette, Xavier
    Papas, Athena
    Grader-Beck, Thomas
    Fisher, Ben A.
    Barcelos, Filipe
    De Vita, Salvatore
    Schulze-Koops, Hendrik
    Moots, Robert
    Junge, Guido
    Woznicki, Janice
    Sopala, Monika
    Luo, Wen-Lin
    Hueber, Wolfgang
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2063 - 2065
  • [44] IANALUMAB (VAY736) SAFETY AND EFFICACY IN PATIENTS WITH SJOGREN'S SYNDROME: 52 WEEK RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL
    Doerner, T.
    Bowman, S. J.
    Fox, R.
    Mariette, X.
    Papas, A.
    Grader-Beck, T.
    Fisher, B. A.
    Barcelos, F.
    De Vita, S.
    Schulze-Koops, H.
    Moots, R. J.
    Junge, G.
    Woznicki, J.
    Sopala, M.
    Luo, W.
    Hueber, W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 87 - 88
  • [45] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [46] Safety and Efficacy Of Etanercept In Early Non-Radiographic Axial Spondyloarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial At 24 Weeks
    Dougados, Maxime
    van der Heijde, Desiree
    Sieper, Joachim
    Braun, Juegen
    Maksymowych, Walter P.
    Citera, Gustavo
    Wei, James Cheng-Chung
    Lenaerts, Jan
    Pedersen, Ronald
    Bonin, Randi
    Mahgoub, Ehab Y.
    Vlahos, Bonnie
    Bukowski, Jack
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S642 - S643
  • [47] Safety and Efficacy Of Subcutaneous Golimumab In Chinese Patients With Active Rheumatoid Arthritis Despite MTX Therapy: Results From a Randomized, Placebo-Controlled, Phase 3 Trial
    Li, Zhanguo
    Zhang, Fengchun
    Kay, Jonathan
    Fei, Kaiyin
    Han, Chenglong
    Zhuang, Yanli
    Wu, Zhong
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S598 - S599
  • [48] Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy
    Li, Zhanguo
    Zhang, Fengchun
    Kay, Jonathan
    Fei, Kaiyin
    Han, Chenglong
    Zhuang, Yanli
    Wu, Zhong
    Hsia, Elizabeth C.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1143 - 1156
  • [49] SAFETY AND EFFICACY OF SUBCUTANEOUS GOLIMUMAB IN CHINESE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE MTX THERAPY: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Li, Z.
    Zhang, F.
    Kay, J.
    Fei, K.
    Han, C.
    Zhuang, Y.
    Wu, Z.
    Hsia, E. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 444 - 444
  • [50] Safety and efficacy of ataluren in nmDMD patients from Study 041, a phase 3, randomized, double-blind, placebo-controlled trial
    McDonald, C.
    Wu, S.
    Gulati, S.
    Komaki, H.
    Ruiz-Garcia, M.
    Kostera-Pruszczyk, A.
    Vlodavets, D.
    Chae, J.
    Jong, Y.
    Karachunski, P.
    Statland, J.
    Lorentzos, M.
    Penematsa, V
    Chou, C.
    Lin, M.
    Werner, C.
    Trifillis, P.
    Gordon, G.
    Klein, M.
    NEUROMUSCULAR DISORDERS, 2022, 32
12345